LYMPHOMA RECRUITMENT

Lymphoma Patient Recruitment Services

Accelerate your lymphoma clinical trials with TheraNovex's specialized recruitment platform. Expert targeting for Hodgkin lymphoma, Non-Hodgkin lymphoma, and all lymphoid malignancies.

Proven Lymphoma Patient Recruitment Results

Our specialized lymphoma recruitment platform delivers faster enrollment across all lymphoid malignancy types and treatment settings.

2,200+

Lymphoma Patients Successfully Recruited

35+

Completed Lymphoma Studies

46%

Faster Enrollment Than Industry Average

94%

Patient Retention Rate in Lymphoma Trials

Comprehensive Lymphoma Patient Recruitment

Expert recruitment across all lymphoma subtypes and treatment lines for accelerated clinical trial enrollment.

Diffuse Large B-Cell Lymphoma (DLBCL)

DLBCL patient recruitment for frontline and relapsed/refractory treatment studies

850+ patients recruited

Hodgkin Lymphoma (HL)

Classical and nodular lymphocyte-predominant Hodgkin lymphoma recruitment

420+ patients recruited

Follicular Lymphoma

Indolent lymphoma recruitment for maintenance therapy and novel agent trials

380+ patients recruited

Mantle Cell Lymphoma

MCL patient recruitment for targeted therapy and combination treatment studies

290+ patients recruited

Peripheral T-Cell Lymphoma (PTCL)

Rare T-cell lymphoma recruitment for specialized treatment and immunotherapy trials

180+ patients recruited

Cutaneous T-Cell Lymphoma (CTCL)

Mycosis fungoides and Sézary syndrome recruitment for targeted therapy studies

150+ patients recruited

Advanced Lymphoma Recruitment Strategies

Multi-channel approach combining digital outreach, hematology networks, and patient advocacy partnerships.

Digital Patient Outreach

Targeted campaigns reaching lymphoma patients through social media, search marketing, and patient portals

Hematology-Oncology Networks

Direct relationships with lymphoma specialists, hematologists, and comprehensive cancer centers

Patient Advocacy Collaboration

Partnerships with lymphoma foundations, support groups, and blood cancer organizations

Pathology and Biomarker Testing

Lymphoma subtyping, flow cytometry, and molecular marker coordination for precision recruitment

Lymphoma Recruitment Process

Patient identification through multiple channels

Lymphoma subtype and staging assessment

Pathology review and biomarker testing coordination

Treatment history and prior therapy evaluation

Site matching based on lymphoma specialization

Enrollment support and retention management

Ready to Accelerate Your Lymphoma Study Enrollment?

Partner with TheraNovex for expert lymphoma patient recruitment. Our specialized platform delivers faster enrollment across all lymphoid malignancies.